当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Deborah Brosnan
Neuromyelitis Optica Spectrum Disorders (NMOSD) and Multiple Sclerosis (MS) are distinct autoimmune diseases that primarily affect the central nervous system. While both conditions involve demyelination and inflammation, their underlying pathophysiological mechanisms and clinical manifestations differ significantly. One intriguing aspect that has garnered recent attention is the concept of brain age gap – a phenomenon where the brain's apparent age, as determined by neuroimaging techniques, deviates from the chronological age of an individual. This phenomenon has been observed in various neurological disorders and may provide valuable insights into the neurodegenerative processes occurring within the brain.
This review aims to explore the presence and significance of the brain age gap in NMOSD and MS. We will delve into the existing literature to comprehend how these disorders contribute to accelerated brain aging and whether the brain age gap holds diagnostic, prognostic, or therapeutic implications. By comparing the pathophysiological mechanisms, clinical presentations, and neuroimaging findings of NMOSD and MS, we seek to unravel whether the brain age gap is a shared feature or distinct between the two diseases. This investigation is crucial not only for advancing our understanding of disease mechanisms but also for developing tailored interventions that target the unique neurodegenerative processes occurring in NMOSD and MS.